A Clinical Pharmacodynamic and Pharmacogenetic Study of OPB-51602 in Patients With Advanced Solid Tumours

NCT01867073 · clinicaltrials.gov ↗

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

OTHER: Biomarker

Sponsor

National University Hospital, Singapore